Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

5:40 PM - 5:45 PM PT

1088 - PURE-MRI: An International Study Assessing Physician Accuracy in Delineating the Prostate and Urethra on Prostate MRI
Speaker: Nguyen, Lily, BS - UCSD Medical School, La Jolla, CA
5:40 PM - 5:45 PM PT

1094 - The Longitudinal Oral Metatranscriptome Associated with Oropharyngeal Cancer Definitive Chemoradiation Toxicity
Speaker: Gogineni, Emile, DO - The Ohio State University, Columbus, OH
5:40 PM - 5:45 PM PT

1100 - A Multi-Model Machine Learning Framework Identifies Resistance-Associated Biomarkers in Axicabtagene Ciloleucel CAR T-Cell Therapy for Large B-Cell Lymphoma
Speaker: Wu, Wei, PhD - Stanford University, San Jose, CA
5:40 PM - 5:45 PM PT

1107 - Irradiated Tumor Cell-Derived Extracellular Vesicles Foster Immunosuppressive Macrophages Formation to Promote Esophageal Squamous Cell Carcinoma Progression
Speaker: Yang, Xi, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
5:45 PM - 5:50 PM PT

1083 - Multi-Institutional Phase II Trial Using Dose Escalated Five Fraction Stereotactic Partial Breast Irradiation (S-PBI) with a Cobalt Stereotactic Unit for Early-stage Breast Cancer
Speaker: Rahimi, Asal, MD, MS - University of Texas Southwestern Medical Center at Dallas, Dallas, TX
5:45 PM - 5:50 PM PT

1089 - Treatment Outcomes and Prognostic Factors of Carbon Ion Radiation Therapy for Localized Prostate Cancer: A Single-Institution Retrospective Study of over 7000 Patients
Speaker: Fukunishi, Kaori, MD - Ion Beam Therapy Center, SAGA-HIMAT Foundation, Tosu, Saga
5:45 PM - 5:50 PM PT

1095 - Combined Liquid Biopsy of On-Treatment Plasma Epstein-Barr Virus DNA with Clinical Stage to Guide Induction Chemotherapy Cycles in Locally Advanced Nasopharyngeal Carcinoma Patients: A Multicenter Development and Validation Study
Speaker: Tang, Linglong, MD, PhD - Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong
5:45 PM - 5:50 PM PT

1101 - Consensus Organ at Risk (OAR) Constraints for Radiotherapy (RT) for Hematologic Malignancies for NCTN Trials
Speaker: Sim, Austin, MD, JD - The Ohio State University Comprehensive Cancer Center, Columbus, OH

Wednesday, October 01

8:00 AM - 8:10 AM PT

351 - A Novel Fluorescence Lifetime Imaging Integrated with Optical Transparent Agents for Quantitative In Vivo Imaging
Speaker: Gao, Shan, PhD - University of Texas Southwestern Medical Center, Dallas, TX
8:00 AM - 9:00 AM PT

GI 4: Quick Pitch: Enhancing Efficacy for Esophageal cancer and Radiation Reponders for Rectal Cancer
Speaker: Kim, Hyun, MD - Washington University School of Medicine, St. Louis, Missouri
8:00 AM - 9:00 AM PT

GI 4: Quick Pitch: Enhancing Efficacy for Esophageal cancer and Radiation Reponders for Rectal Cancer
Speaker: Koenig, Julie, MD - Mass General Brigham, Somerville, MA
8:00 AM - 9:00 AM PT

GU 9: Quick Pitch: Predictive Markers in Prostate Cancer
Speaker: Miyamoto, David, MD, PhD - Massachusetts General Hospital, Boston, MA